Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) dropped 2.5% during trading on Thursday . The company traded as low as $1.50 and last traded at $1.55. Approximately 13,161 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 26,677 shares. The stock had previously closed at $1.59.
Cocrystal Pharma Price Performance
The company’s fifty day moving average is $1.51 and its two-hundred day moving average is $1.76.
Cocrystal Pharma (NASDAQ:COCP – Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.52) by $0.29. Analysts expect that Cocrystal Pharma, Inc. will post -1.85 earnings per share for the current year.
About Cocrystal Pharma
Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.
Further Reading
- Five stocks we like better than Cocrystal Pharma
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
- How to Profit From Value Investing
- Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill
- 3 REITs to Buy and Hold for the Long Term
- Super Micro Computer Stock’s Rally Backed by Strong Financials
Receive News & Ratings for Cocrystal Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cocrystal Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
